Cargando…
Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?
Background: Idiopathic pulmonary fibrosis (IPF) is a rare and severe disease with a median survival of ∼3 years. Several risk factors have been identified, such as age, genetic predisposition, tobacco exposure, and gastro-oesophageal reflux disease (GERD). Prevalence of GERD in IPF is high and may a...
Autores principales: | Ruaro, Barbara, Pozzan, Riccardo, Confalonieri, Paola, Tavano, Stefano, Hughes, Michael, Matucci Cerinic, Marco, Baratella, Elisa, Zanatta, Elisabetta, Lerda, Selene, Geri, Pietro, Confalonieri, Marco, Salton, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412643/ https://www.ncbi.nlm.nih.gov/pubmed/36015181 http://dx.doi.org/10.3390/ph15081033 |
Ejemplares similares
-
Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
por: Ruaro, Barbara, et al.
Publicado: (2022) -
Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy
por: Ruaro, Barbara, et al.
Publicado: (2023) -
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study
por: Ruaro, Barbara, et al.
Publicado: (2022) -
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients
por: Ruaro, Barbara, et al.
Publicado: (2022) -
Editorial: Pulmonary fibrosis: One manifestation, various diseases
por: Ruaro, Barbara, et al.
Publicado: (2022)